Duffour J - Search Results

1

MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy.

Nougaret S, Rouanet P, Molinari N, Pierredon MA, Bibeau F, Azria D, Lemanski C, Assenat E, Duffour J, Ychou M, Reinhold C, Gallix B. Nougaret S, et al. Among authors: duffour j. Radiology. 2012 May;263(2):409-18. doi: 10.1148/radiol.12111263. Epub 2012 Mar 21. Radiology. 2012. PMID: 22438364

2

[Irinotecan for the treatment of metastatic colorectal cancer].

Assenat E, Duffour J, Ychou M. Assenat E, et al. Among authors: duffour j. Bull Cancer. 2006 May;93(5):507-15. Bull Cancer. 2006. PMID: 16777630 Free article. Review. French.

3

A limited sampling strategy to estimate the pharmacokinetic parameters of irinotecan and its active metabolite, SN-38, in patients with metastatic digestive cancer receiving the FOLFIRI regimen.

Poujol S, Pinguet F, Ychou M, Abderrahim AG, Duffour J, Bressolle FM. Poujol S, et al. Among authors: duffour j. Oncol Rep. 2007 Dec;18(6):1613-321. Oncol Rep. 2007. PMID: 17982652

4

Value of serial carcinoembryonic antigen levels in evaluating the response to chemotherapy in patients with advanced digestive cancers.

Ychou M, Duffour J, Kramar A, Grenier J. Ychou M, et al. Among authors: duffour j. Oncol Rep. 1998 Sep-Oct;5(5):1245-50. doi: 10.3892/or.5.5.1245. Oncol Rep. 1998. PMID: 9683844

5

Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial).

Duffour J, Bouché O, Rougier P, Milan C, Bedenne L, Seitz JF, Buecher B, Legoux JL, Ducreux M, Vetter D, Raoul JL, François E, Ychou M. Duffour J, et al. Anticancer Res. 2006 Sep-Oct;26(5B):3877-83. Anticancer Res. 2006. PMID: 17094417 Free article. Clinical Trial.

6

Clinical impact of intesified 5-Fluorouracil-based chemotherapy using a prospective pharmacokinetically-guided dosing approach: comparative study in elderly and non-elderly patients with metastatic colorectal cancer.

Duffour J, Roca L, Bressolle F, Abderrahim AG, Poujol S, Pinguet F, Ychou M. Duffour J, et al. J Chemother. 2010 Jun;22(3):179-85. doi: 10.1179/joc.2010.22.3.179. J Chemother. 2010. PMID: 20566423

7

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.

Duffour J, Gourgou S, Desseigne F, Debrigode C, Mineur L, Pinguet F, Poujol S, Chalbos P, Bressole F, Ychou M. Duffour J, et al. Cancer Chemother Pharmacol. 2007 Aug;60(3):383-9. doi: 10.1007/s00280-006-0372-9. Epub 2006 Nov 24. Cancer Chemother Pharmacol. 2007. PMID: 17124595 Clinical Trial.

8

[Clinical Practice Guidelines 2004. Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach: radiotherapy (therapeutic evaluation)].

Ychou M, Gory-Delabaere G, Blanc P, Bosquet L, Duffour J, Giovannini M, Guillemin F, Lemanski C, Marchal F, Masson B, Merrouche Y, Monges G, Adenis A, Bosset JF, Bouché O, Conroy T, Pezet D, Triboulet JP; Fédération nationale des centres de lutte contre le cancer (FNCLCC); Fédération hospitalière de France (FHF); Fédération nationale de Cancérologie des CHRU (FNCHRU); Fédération française de cancérologie des CHG (FFCCHG); Centres régionaux de lutte contre le cancer (CRLCC). Ychou M, et al. Among authors: duffour j. Bull Cancer. 2005 Apr;92(4):381-409. Bull Cancer. 2005. PMID: 15888395 Free article. Review. French.

9

Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.

Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J. Ychou M, et al. Among authors: duffour j. Dis Markers. 2000;16(3-4):105-10. doi: 10.1155/2000/595492. Dis Markers. 2000. PMID: 11381189 Free PMC article.

10

Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen.

Ychou M, Duffour J, Kramar A, Debrigode C, Gourgou S, Bressolle F, Pinguet F. Ychou M, et al. Among authors: duffour j. Cancer Chemother Pharmacol. 2003 Oct;52(4):282-90. doi: 10.1007/s00280-003-0658-0. Epub 2003 Jun 19. Cancer Chemother Pharmacol. 2003. PMID: 12827293 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters